references
- Frye CA. An overview of oral contraceptives: mechanism of action and clinical use. Neurology 2006;66(6 Suppl. 3):S29–36.
- Brunnhuber S, Kirchengast S. Use of the oral contraceptive pill by Austrian adolescents with emphasis on the age of onset, side effects, compliance and lifestyle. Coll Antropol 2002;26:467–75.
- Robinson SA, Dowell M, Pedulla D, McCauley L. Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanisms? Med Hypotheses 2004;63:268–73.
- Duke JM, Sibbritt DW, Young AF. Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception 2007;75:27–31.
- Kulkarni J. Depression as a side effect of the contraceptive pill. Expert Opin Drug Saf 2007;6:371–4.
- Segebladh B, Borgström A, Odlind V, . Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception 2009;79:50–5.
- Berenson AB, Odom SD, Breitkopf CR, Rahman M. Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills. Am J Obstet Gynecol 2008;199:351.e1–12.
- Douma SL, Husband C, O’Donnell ME, . Estrogen-related mood disorders: reproductive life cycle factors. ANS Adv Nurs Sci 2005;28:364–75.
- Lakdawalla Z, Hankin BL, Mermelstein R. Cognitive theories of depression in children and adolescents: a conceptual and quantitative review. Clin Child Fam Psychol Rev 2007;10:1–24.
- Kendler K, Gardner CO, Prescott CA. Toward a comprehensive development model for major depression in women. Am J Psychiatry 2002;159:1133–45.
- Spence SH, Shortt AL. Research review: can we justify the widespread dissemination of universal, school-based interventions for the prevention of depression among children and adolescents? J Child Psychol Psychiatry 2007;48:526–42.
- Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006;26:10332–48.
- Wiréhn AB, Foldemo A, Josefsson A, Lindberg M. Use of hormonal contraceptives in relation to antidepressant therapy: a nationwide population-based study. Eur J Contracept Reprod Health Care 2010;15:41–7.
- The National Board of Health and Welfare. Health care report 2009 (In Swedish). Stockholm, Sweden: The National Board of Health and Welfare 2009.
- Wettermark B, Hammar N, Fored CM, . The new Swedish Prescribed Drug Register – Opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16:726–35.
- Statistics Sweden Befolkningsstatistik [The Total Population Register]. Accessed 15 September 2009 from: http://www.ssd.scb.se/databaser/makro/start.asp
- Armitage P, Berry G, Matthews JNS. Statistical methods in medical research, 4th edn. Oxford: Blackwell Science Ltd. 2002: 117.
- Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied linear statistical models, 4th edn. Chicago, IL: Irwin 1996: 1215.
- Oinonen KA, Mazmanian D. To what effect do oral contraceptives influence mood and affect? J Affect Disord 2002;70:229–40.
- Birkhäuser M. Depression, menopause and estrogens: is there a correlation? Maturitas 2002;41(Suppl. 1):S3–8.
- Deecher D, Andree TH, Sloan D, Schechter LE. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008;33:3–17.
- Ancelin ML, Scali J, Ritchie K. Hormonal therapy and depression: are we overlooking an important therapeutic alternative? J Psychosom Res 2007;62:473–85.
- Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary report. J Psychiatr Res 2008;42:247–51.
- Bloch M, Rotenberg N, Koren D, Klein E. Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry 2006;28:3–8.
- Klier CM, Muzik M, Dervic K, . The role of estrogen and progesterone in depression after birth. J Psychiatr Res 2007;41:273–9.
- Sangi-Haghpeykar H, Poindexter AN3rd, Bateman L, Ditmore JR. Experiences of injectable contraceptive users in an urban setting. Obstet Gynecol 1996;88: 227–33.
- Archer B, Irwin D, Jensen K, . Depot medroxyprogesterone. Management of side-effects commonly associated with its contraceptive use. J Nurs Midwifery 1997;42:104–11.
- Fraser IS, Dennerstein GJ. Depo-Provera use in an Australian metropolitan practice. Med J Aust 1994;160: 553–6.
- Civic D, Scholes D, Ichikawa L, . Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception 2000;61:385–90.
- Westhoff C, Wieland D, Tiezzi L. Depression in users of depo-oxyprogesterone acetate. Contraception 1995;51: 351–4.
- Westhoff C, Truman C, Kalmuss D, . Depressive symptoms and Depo-Provera. Contraception 1998;57:237–40.
- Gupta N, O’Brien R, Jacobsen LJ, . Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study. J Pediatr Adolesc Gynecol 2001;14:71–6.
- Chang YT, Hayter M, Wu SC. A systematic review and meta-ethnography of the qualitative literature: experiences of the menarche. J Clin Nurs 2010;19: 447–60.